Atlas Venture Life Science Advisors’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.9M | Hold |
|
|||||
|
2025
Q1 | $95.5M | Buy |
|
|||||
|
2024
Q4 | $189M | Sell |
|
|||||
|
2024
Q3 | $288M | Hold |
|
|||||
|
2024
Q2 | $283M | Hold |
|
|||||
|
2024
Q1 | $228M | Sell |
|
|||||
|
2023
Q4 | $131M | Hold |
|
|||||
|
2023
Q3 | $88.6M | Hold |
|
|||||
|
2023
Q2 | $111M | Hold |
|
|||||
|
2023
Q1 | $114M | Buy |
|
|||||
|
2022
Q4 | $114M | Buy |
|
|||||
|
2022
Q3 | $113M | Hold |
|
|||||
|
2022
Q2 | $61.4M | Hold |
|
|||||
|
2022
Q1 | $86.1M | Hold |
|
|||||
|
2021
Q4 | $106M | Buy |
|